SubHero Banner

Syndros (dronabinol) – New formulation approval

July 5, 2016 – Insys Therapeutics announced the FDA approval of Syndros (dronabinol) oral solution, indicated in adults for the treatment of anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS) and for nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Download PDF